Formulation Development

Pharmaceutical formulation development and optimisation of formulations for powders, capsules, liquids, solids, inhaled and nasal drug formulations

Formulation development to determine the optimal dosage form, composition and manufacturing route is a fundamental part of pharmaceutical product development.

Getting a pharmaceutical formulation development right helps to optimise drug delivery performance and product stability. Complex dosage forms, in particular, inhaled and nasal products can present unique challenges for controlling the performance of the drug product and impact bioavailability.

Our formulation development teams offer design and optimisation of formulations for powders, capsules, liquids and solids, semi-solids, inhaled, nasal, nebulised and topical drug formulations.

We provide focused understanding from an early stage of development for your new chemical entities (NCE) and generic products, starting with early feasibility through to development support, Phase I and Phase II clinical trials and transfer to commercial manufacturing.

Our expertise helps accelerate project timelines and includes pre-formulation, excipient-API compatibility assessment and optimisation, physicochemical testing, formulation screening, lab scale formulation and accelerated stability studies to achieve the desired characteristics.

The Intertek formulation development team enables small amounts of drug product materials to be developed using experimental design methodologies supported by testing at every stage with key performance analytics including solubility, dissolution, solid state characterisation and powder and particle morphology studies.

Integrated with analysis and stability storage, our specialists can screen a wide range of formulations in a timely and cost-effective manner in order to identify the most promising formulation to progress through to further development. As a result, we can save you time by reducing method and technology transfer time as well as effort.

With service provision including raw material quality control, scale-up, pilot batch manufacturing and testing, GMP clinical batch manufacturing, impurities testing, as well as release testing with QP release, we offer a one-source solution for supplies for use in Phase I and II clinical trials.

With dedicated teams of experienced analysts and formulators, we offer a truly flexible, dedicated formulation specialists to help you arrive at the optimal formulation and manufacturing process for your API.

 
Need help or have a question? +44 1763 261648
 

Need help or have a question?

+44 1763 261648
UK:
+44 1763 261648